Fertility
102
18
18
53
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Research Maturity
53 completed trials (52% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.8%
8 terminated out of 102 trials
86.9%
+0.4% vs benchmark
13%
13 trials in Phase 3/4
13%
7 of 53 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 53 completed trials
Clinical Trials (102)
Developing Resource Interventions for Healthcare Professionals and Patients to Improve Knowledge About Fertility in Primary Ciliary Dyskinesia
An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation
Ablative Technique For Ovarian Preservation In Endometrioma
An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin
Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification
Effect of Walnuts on Sperm Parameters and Male Fertility
Impact of Sequential Chemotherapy on Young Patients Breast Cancer Treated Fertility
Reproductive Prognosis in Women Seeking Offspring After Medical or Surgical Therapy for Endometriosis
Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.
Fertility Outcomes In Young Breast Cancer Patients And Their Prognosis And Offspring Health
Plan A Occlusion and Reversal System Feasibility Study
Smartphone vs Manual Interpretation of Biomarkers for Ovulation and Luteal Phase Detection (SMOM Study)
Secretory Azoospermia and FDG (Fluoro Deoxyglucose) PET-CT
A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod Pump
Evaluation of the Impact of Multiple Sclerosis and Its Treatments on Women Fertility
MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse.
Validation of Donor Oocytes Semi-automated Vitrification
Observational Study to Evaluate Fertility in Women Between 32 and 38 Years Old Treated With the Ovosicare® Fertility
Association Between Euploid Embryo Grade and Maternal Age
New Strategies to Evaluate the Reproductive Tract Microbiome